Naloxone Modulates NK-Cell Activity of Human Peripheral Blood Lymphocytes Like an Opioid Agonist

References

• Sibinga N. E.S., Goldstein A. Opioid Peptides and Opioid Receptors in Cells of the Immune System. Annu. Rev. Immunol. 1988; 6: 219
   PubMed Web of Science ®Google Scholar
• Lord J. A.H., Waterfield A. A., Hughes J., Kosterlitz H. W. Endogenous Opioid Peptides: Muliple Agonists and Receptors. Nature 1977; 267: 495
   PubMed Web of Science ®Google Scholar
• Mather L. E. Pharmacology of Opioids. Part I. Basic Aspects. Med. J. Aust. 1986; 144: 424
   PubMedGoogle Scholar
• Mehrishi J. N., Mills I. H. Opiate Receptors on Lymphocytes and Platelets in Man. Clin. Immunol. Immunopathol. 1983; 27: 240
   PubMedGoogle Scholar
• Carr D. J.J., Kim C. H., DeCosta B., Jacobson A. E., Kenner C. R., Blalock J. E. Evidence for a d-Class Opioid Receptors on Cells of the Immune System. Cell. Immunol. 1988; 116: 44
   PubMed Web of Science ®Google Scholar
• Madden J. J., Donahoe R. M., Zwemmer-Collins J., Shafer D. A., Falek A. Binding of Naloxone to Human T-Lymphocytes. Biochem. Pharmacol. 1987; 36: 4103
   PubMed Web of Science ®Google Scholar
• Plotnikoff N. P., Murgo A. J., Moller G. C., Corder C. N., Faith R. E. Enkephalins: Immunomodulators. Fed. Proc. 1985; 44: 118
   PubMedGoogle Scholar
• Kusnecov A. W., Husband A. J., King M. G., Pang G., Smith R. In vivo Effects of β-Endorphin on Lymphocyte Proliferation and Interleukin 2 Production. Brain Behav. Immun. 1987; 1: 88
   PubMedGoogle Scholar
• Marotti T., Batinić D. Enkephalins Regulate In Vitro Antibody Response of Human Lymphocytes. Period, biol. 1990; 92: 197
   Web of Science ®Google Scholar
• Marotti T., Haberštok H. Naloxone is an Inappropriate Antagonist of Met-Enkephalin Modulated Superoxide Release. Brain Behav. Immun., (in press)
   Google Scholar
• Murgo A. J. Modulation of Murine Melanoma Growth by Naloxone. Cancer Lett. 1989; 44: 137
   PubMedGoogle Scholar
• Murgo A. J. Inhibition of B16-BL6 Melanoma Growth in Mice by Methionine-Enkephalin. J. Natl. Cancer. Inst. 1985; 75: 341
   PubMedGoogle Scholar
• Scholar E. M., Violi L., Hexum T. D. Antimetastatic Activity of Enkephalin-Like Peptides. Cancer Lett. 1987; 35: 133
   PubMedGoogle Scholar
• Mathews P. M., Froelich C. J., Sibbitt W. L., Bankhurst A. D. Enhancement of Natural Cytotoxicity by β-Endorphin. J. Immunol. 1983; 130: 1658
   PubMed Web of Science ®Google Scholar
• Faith R. E., Liang H. J., Murgo A. J., Plotnikoff N. P. Neuroimmunomodulation with Enkephalins: Enhancement of Human Natural Killer (NK) Cell Activity In Vitro. Clin. Immunol. Immunopathol. 1984; 31: 412
   PubMedGoogle Scholar
• Faith R. E., Murgo A. J. Inhibition of Pulmonary Metastasis and Enhancement of Natural Killer Cell Activity by Methionone-Enkephalin. Brain Behav. Immun. 1988; 2: 114
   PubMedGoogle Scholar
• Herberman R. B., Holden H. T. Natural Killer Cells as Antitumor Effector Cells. J. Natl. Cancer Inst. 1979; 62: 441
   PubMed Web of Science ®Google Scholar
• Hanna N., Fidler I. J. Role of Natural Killer Cells in the Destruction of Circulating Tumor Emboli. J. Natl. Cancer Inst. 1980; 65: 801
   PubMed Web of Science ®Google Scholar
• Robertson M. J., Ritz J. Biology and Clinical Relevance of Human Natural Killer Cells. Blood 1990; 76: 2421
   PubMed Web of Science ®Google Scholar
• Gabrilovac J., Antica M., Osmak M. In Vivo Bidirectional Modulation of Mouse Natural Killer (NK) Cell Cytotoxic Activities by Leu-Enkephalin. Reversibility by Naloxone. Life Sci 1992; 50: 29
   PubMed Web of Science ®Google Scholar
• Kay N. E., Morley J. E., Allen J. I. Interaction Between Endogenous Opioids and IL-2 on PHA-Stimulated Human Lymphocytes. Immunology 1990; 70: 485
   PubMed Web of Science ®Google Scholar
• Trinchieri G. Biology of Natural Killer Cells. Adv Immunol. 1989; 47: 187
   PubMed Web of Science ®Google Scholar
• Boyum A. Separation of Leukocytes From Blood and Bone Marrow. Scand J. Clin. Lab. Invest. 1968; 21: 77, (Suppl. 97)
   PubMed Web of Science ®Google Scholar
• Gabrilovac J., Rajić Lj., Martin-Kleiner I., Osmak M., Batinić D., Tiefenbach A., Boranić M. Deffect of NK Activity in Children with Untreated Acute Lymphocytic Leukemia (ALL.) I. Dependence on the Blast Count and Phenotype, and Response to Exogenous and Endogenous Alpha-Interferon. J. Clin. Lab. Immunol. 1989; 29: 9
   PubMedGoogle Scholar
• Lozzio C. B., Lozzio B. B. Human Chronic Myelogenous Leukemia Cell Line with Positive Philadelphia Chromosome. Blood 1975; 45: 321
   PubMed Web of Science ®Google Scholar
• Gabrilovac J., Martin-Kleiner I., Ikić-Sutlić M., Osmak M. Leu-Enkephalin and α-Interferon Interact in Modulation of the NK Activity of Human Peripheral Blood Lymphocytes. Med. Sci. Res. 1990; 18: 161
   Google Scholar
• Goldstein A., Naidu A. Multiple Opioid Receptors: Ligand Selectivity Profiles and Binding Site Signatures. Mol. Pharmacol. 1989; 36: 265
   PubMed Web of Science ®Google Scholar
• Brown S. L., Van Epps D. E. Suppression of T-Lymphocyte Chemotactic Factor Production by the Opioid Peptides β-Endorphin and Met-Enkephalin. J. Immunol. 1985; 134: 3384
   PubMed Web of Science ®Google Scholar
• Marotti T., Šverko V., Hršak I. Modulation of Superoxide Anion Release From Human Polymorphonuclear Cells by Met- and Leu-Enkephalin. Brain Behav. Immun. 1990; 4: 13
   PubMed Web of Science ®Google Scholar
• Millar D. B., Hough C. J., Mazorow D. L., Gootenberg J. E. β-Endorphin's Modulation of Lymphocyte Proliferation is Dose, Donor and Time Dependent. Brain Behav. Immun. 1990; 4: 232
   PubMed Web of Science ®Google Scholar
• Oleson D. R., Johnson D. R. Regulation of Human Natural Killer Cytotoxicity by Enkephalins and Selective Opiate Agonists. Brain Behav Immun 1988; 2: 171
   PubMedGoogle Scholar
• Traber J., Gullis R., Hamprecht B. Influence of Opiates on the Levels of Adenosine 3′:5′-Cyclic Monophosphate in Neuroblastoma × Glioma Hybrid Cells. Life Sci. 1975; 16: 1863
   PubMed Web of Science ®Google Scholar
• Kavelaars A., Ballieux R. E., Heijnen C. J. Differential Effects of β-Endorphin on cAMP Levels in Human Peripheral Blood Mononuclear Cells. Brain Behav. Immun. 1990; 4: 171
   PubMed Web of Science ®Google Scholar
• Martin-Kleiner I., Omak M., Gabrilovac J. Regulation of NK Cell Activity and the Level of the Intracellular cAMP in Human Peripheral Blood Lymphocytes by Met-Enkephalin. Res. Exp. Med. 1992; 192: 145
   PubMedGoogle Scholar
• Koyasu S., Tagaya Y., Sugie K., Yonehara S., Yodoi J., Yahara I. The Expression of IL-2R α-Chain is Enhanced by Activation of Adenylate Cyclase in Large Granular Lymphocytes and Natural Killer Cells. J. Immunol. 1991; 146: 233
   PubMedGoogle Scholar
• Schettini G., Florio T., Meucci O., Landolfi E., Grimaldi M., Ventra C., Marino A. Interleukin-1 Modulation of Anterior Pituitary Function. Effects of Prolactin Release and Postreceptor Transducing Mechanisms. Ann. N.Y. Acad. Sci. 1990; 594: 489
   Google Scholar
• Brown S. L., Van Epps D. E. Opioid Peptides Modulate Production of Interferon γ by Human Mononuclear Cells. Cell. Immunol. 1986; 103: 19
   PubMedGoogle Scholar
• Mandler R. N., Biddison W. E., Mandler R., Serrate S. A. β-Endorphin Augments the Cytolytic Activity and Interferon Production of Natural Killer Cells. J. Immunol. 1986; 136: 934
   PubMed Web of Science ®Google Scholar